BioSpace News Archive

Policy

See a more complete picture of your health with Index BPM, an FDA-cleared smart blood pressure monitor from Garmin

Garmin International, Inc., a unit of Garmin Ltd., announced the Index™ BPM, its first smart blood pressure monitor that lets users measure and track systolic and diastolic blood pressure at home or on the go.

September 20, 2022
·
4 min read
Genetown

Vizgen Unveils MERSCOPE™ Protein Co-detection Kit Enabling Simultaneous Imaging of Transcripts and Proteins in a Single Experiment

Vizgen Unveils MERSCOPE™ Protein Co-detection Kit Enabling Simultaneous Imaging of Transcripts and Proteins in a Single Experiment.

September 20, 2022
·
2 min read
Genetown

Alnylam Receives Approval in Europe for AMVUTTRA® (vutrisiran) for the Treatment of Hereditary Transthyretin-mediated (hATTR) Amyloidosis in Adult Patients with Stage 1 or Stage 2 Polyneuropathy

Alnylam Receives Approval in Europe for AMVUTTRA ® (vutrisiran) for the Treatment of Hereditary Transthyretin-mediated (hATTR) Amyloidosis in Adult Patients with Stage 1 or Stage 2 Polyneuropathy.

September 20, 2022
·
10 min read
FDA

AVROBIO Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration (FDA) for First Gene Therapy in Development for Cystinosis

AVROBIO, Inc today announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to AVR-RD-04.

September 20, 2022
·
7 min read
Business

LUNGevity Foundation Issues Five Health Equity and Inclusiveness Research Awards

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is pleased to announce the recipients of their 2022 Health Equity and Inclusiveness Research Awards.

September 20, 2022
·
6 min read
FDA

Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy

Alterity Therapeutics today announced the approval of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) to allow evaluation of ATH434 in individuals with Multiple System Atrophy (MSA), a rare and highly debilitating Parkinsonian disorder.

September 20, 2022
·
4 min read
Business

Gain Therapeutics Announces Promotion of Matthias Alder to Chief Executive Officer

Gain Therapeutics, Inc. today announced that Matthias Alder, the Company’s current Chief Operating Officer, has been appointed as the Company’s Chief Executive Officer, effective immediately.

September 20, 2022
·
5 min read
Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit

Virax Biolabs announced today the distribution of a Monkeypox Virus Antigen Rapid Test Kits which has been launched in markets accepting the CE mark, such as the European Union.

September 20, 2022
·
3 min read
Business

Ludwig Enterprises and Emerson Urology Associates Plan Bladder Cancer BCG Immunotherapy Study

Ludwig Enterprises is pleased to announce that the Company has started discussions with Emerson Urology Associates, Concord, MA regarding initiation of a clinical study to evaluate the response of bladder cancer patients to BCG immunotherapy.

September 20, 2022
·
3 min read
Business

Think Research Announces Approximately $12.8 Million of New BioPharma Contracts Signed During Q3 2022

Think Research Corporation has signed multiple new contracts in the third quarter worth approximately $12.8 million.

September 20, 2022
·
10 min read